These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36839947)

  • 21. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics.
    Chaudhari P; Ghate VM; Lewis SA
    Eur J Pharm Biopharm; 2021 Apr; 161():80-99. PubMed ID: 33607239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular Drug Delivery: Present Innovations and Future Challenges.
    Gote V; Sikder S; Sicotte J; Pal D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.
    Ponzini E; Astolfi G; Grandori R; Tavazzi S; Versura P
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact Lenses as Ophthalmic Drug Delivery Systems: A Review.
    Franco P; De Marco I
    Polymers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations.
    Varela-Fernández R; Díaz-Tomé V; Luaces-Rodríguez A; Conde-Penedo A; García-Otero X; Luzardo-Álvarez A; Fernández-Ferreiro A; Otero-Espinar FJ
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32188045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Insights into Targeting Strategies for the Effective Therapy of Diseases of the Posterior Eye Segment.
    Pimple P; Sawant A; Nair S; Sawarkar SP
    Crit Rev Ther Drug Carrier Syst; 2024; 41(2):1-50. PubMed ID: 37938189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Nanogels for Topical Drug Delivery in Ocular Diseases.
    Wu Y; Tao Q; Xie J; Lu L; Xie X; Zhang Y; Jin Y
    Gels; 2023 Apr; 9(4):. PubMed ID: 37102904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology-based formulations to amplify intraocular bioavailability.
    Kagkelaris K; Panayiotakopoulos G; Georgakopoulos CD
    Ther Adv Ophthalmol; 2022; 14():25158414221112356. PubMed ID: 35873277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atropine in topical formulations for the management of anterior and posterior segment ocular diseases.
    García Del Valle I; Alvarez-Lorenzo C
    Expert Opin Drug Deliv; 2021 Sep; 18(9):1245-1260. PubMed ID: 33787441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraocular lenses as drug delivery devices.
    Topete A; Saramago B; Serro AP
    Int J Pharm; 2021 Jun; 602():120613. PubMed ID: 33865952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
    Aburahma MH; Mahmoud AA
    AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of commercial soft contact lenses for ocular drug delivery: A review.
    Fan X; Torres-Luna C; Azadi M; Domszy R; Hu N; Yang A; David AE
    Acta Biomater; 2020 Oct; 115():60-74. PubMed ID: 32853799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
    Wu KY; Joly-Chevrier M; Akbar D; Tran SD
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical-loaded contact lenses as an ocular drug delivery system: A review of critical lens characterization methodologies with reference to ISO standards.
    Nguyen DCT; Dowling J; Ryan R; McLoughlin P; Fitzhenry L
    Cont Lens Anterior Eye; 2021 Dec; 44(6):101487. PubMed ID: 34353748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to prolong the residence time of drug delivery systems on ocular surface.
    Grassiri B; Zambito Y; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin In Situ Gelling Polymeric Insert with Enhanced Ocular Performance.
    Abdelkader H; Wertheim D; Pierscionek B; Alany RG
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33260494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymeric Materials for Eye Surface and Intraocular Applications.
    Karayilan M; Clamen L; Becker ML
    Biomacromolecules; 2021 Feb; 22(2):223-261. PubMed ID: 33405900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
    Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of polymers in intraocular drug delivery systems.
    Alhalafi AM
    Oman J Ophthalmol; 2017; 10(1):3-8. PubMed ID: 28298856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.